The state of Minnesota and pharmaceutical company Eli Lilly have reached an agreement to resolve a lawsuit regarding the excessive pricing of insulin. As part of the deal, the cost of insulin will be capped at $35 per month.
ST. PAUL, Minn. (AP) — Minnesota has reached a settlement with Eli Lilly and Co. in a price gouging lawsuit against the country’s three biggest insulin manufacturers that guarantees that Minnesotans can now buy Lilly-produced insulin for only $35 a month for the next five years, Attorney General Keith Ellison announced Wednesday. The resolution is
READ MORE